ClearPoint Neuro reported total operating expenses of $11.3 million in the quarter. The company ended the period with $12.4 million in cash and cash equivalents. “Our 2025 fiscal year is off to a ...
ClearPoint Neuro (NASDAQ:CLPT) just reported results for the first quarter of 2024. ClearPoint Neuro reported earnings per share of -16 cents. This was above the analyst estimate for EPS of -19 cents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results